Pharmaniaga exits PN17 status


KUALA LUMPUR: Pharmaniaga Bhd will be uplifted from Practice Note 17 (PN17) status effective March 17 after regularising its financial condition.

In a statement, Bursa Malaysia Securities Bhd said the uplift will take effect at 9am on Tuesday, as the pharmaceutical group no longer triggers any of the criteria under Paragraph 2.1 of PN17 under the Main Market Listing Requirements.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Chip veteran raises Malaysia E&E export forecast to US$223bil
Axiata 1H patami more than doubles to RM717.2mil
AI adoption powering industrial profit growth
Sedania returns to profitability in FY26
Farm Fresh posts net profit of RM26.82mil in 1Q amid elevated costs
Malaysia's international reserve assets at US$132.07bil as of end-July
Malaysia's PPI rises 9.7% in July 2026
ASM 2 Wawasan declares income distribution amounting to RM1.31bil, highest in 7 years
Malaysia's export unit value index up 0.6% in July 2026 -- DOSM
CIMB's 2Q net profit rises to RM1.94bil, declares 19.65c div/share

Others Also Read